Cleared Traditional

K121369 - NEURODYN RUBY MUSCLE STIMULATOR, NEURODYN AUSSIE MUSCLE STIMULATOR

K121369 is an FDA 510(k) clearance for NEURODYN RUBY MUSCLE STIMULATOR, manufactured by Ibramed Equipamentos Medicos. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 226-day FDA review.

K121369 · Ibramed Equipamentos Medicos · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
226d
Days
Class 2
Risk

K121369 is an FDA 510(k) clearance for the NEURODYN RUBY MUSCLE STIMULATOR, NEURODYN AUSSIE MUSCLE STIMULATOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Ibramed Equipamentos Medicos (Aventura, US). The FDA issued a Cleared decision on December 19, 2012 after a review of 226 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ibramed Equipamentos Medicos devices

FDA 510(k) Submission Details - K121369

510(k) Number K121369 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2012
Decision Date December 19, 2012
Days to Decision 226 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 149d · This submission: 226d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 346
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K121369.
JIAJIAN POINTOSELECT DIGITAL
K123958 · Wuxi Jiajian Medical Instrument Co., Ltd. · Oct 2013
SENSUS
K130919 · Neurometrix, Inc. · Jul 2013
GEM-STIM COMBO STIMULATOR
K122948 · Gemore Technology Co, Ltd. · Dec 2012
STERLING MEDICAL IMPULSE 3 STIMULATOR
K121305 · Armstrong Industries, Inc. Dha Mediquip Int. Dha S · Sep 2012
WITOUCH PRO
K120398 · Hollywog, LLC · Aug 2012
SENSUS
K121184 · Neurometrix, Inc. · Aug 2012